SLDB logo

Solid Biosciences (SLDB)

Profile

Full Name

Solid Biosciences Inc.

Ticker Symbol

NASDAQ: SLDB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 26, 2018

Indexes

Not included

Website

http://www.solidbio.com

Employees

100

Key Details

Price

$5.03(+3.29%)

Market cap

$389.90M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$3.06(+36.65% YoY)

PE ratio

-

Next earnings date

Aug 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $5.03
    SLDB price is $5.03

    30-Day Relative Volume

    0.41
    SLDB 30-day relative volume is 0.41

    Price Performance

    Price Most recent change

    +3.29%
    SLDB price was up +3.29% on Jul 3, 2025

    Price YTD change

    +25.75%
    SLDB price is up +25.75% since January 1st

    Price 1-year change

    -15.75%
    SLDB price is down -15.75% year-on-year

    Price 3-year change

    -41.78%
    SLDB price is down -41.78% over the past 3 years

    Price Range

    Price All-time high

    $822.60
    SLDB price is currently -99.39% below its historical high of $822.60

    Price 3-year low

    $1.81
    SLDB price is currently +177.90% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $389.90M
    SLDB market capitalization is $389.90 million

    Market cap 3-year change

    +499.22%
    SLDB market capitalization is up +499.22% over the past 3 years

    Market cap All-time high

    $1.83B
    SLDB market capitalization is currently -78.72% below its historical high of $1.83 billion

    Market cap sector rank

    63.33%
    SLDB market capitalization is higher than 63.33% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +101.07%
    SLDB shares outstanding is up +101.07% year-on-year

    Shares Outstanding 3-Year Change

    +929.28%
    SLDB shares outstanding is up +929.28% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.63
    SLDB beta is 1.63

    200-day SMA

    $4.62
    SLDB price is currently +8.86% above its 200-day simple moving average

    50-day SMA

    $3.79
    SLDB price is currently +32.82% above its 50-day simple moving average

    RSI

    62.16
    SLDB 14-day relative strength index is 62.16

    Volume

    0.41
    SLDB 30-day relative volume is 0.41

    ATR

    $0.37
    SLDB average true range is $0.37

    10-day Historical Volatility

    73.20%
    SLDB 10-day historical volatility is 73.20%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    SLDB annual revenue value is unknown

    Revenue Analysts estimate

    -
    SLDB annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    SLDB annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    SLDB annual revenue is unknown

    EPS

    EPS

    -$3.06
    SLDB annual earnings per share is -$3.06

    EPS Analysts estimate

    -$2.14
    SLDB annual earnings per share is currently +42.72% higher than the consensus analysts' forecast

    EPS 1-year change

    +36.65%
    SLDB annual earnings per share is up +36.65% year-on-year

    EPS Sector rank

    29.02%
    SLDB annual earnings per share is higher than 29.02% of companies in Healthcare sector

    Profit

    Gross profit

    -
    SLDB annual gross profit value is unknown

    Gross margin

    -
    SLDB annual gross profit margin value is unknown

    Operating profit

    -$129.73M
    SLDB annual operating income is -$129.73 million

    Operating margin

    -
    SLDB annual operating profit margin value is unknown

    Net income

    -$124.70M
    SLDB annual net profit is -$124.70 million

    Net margin

    -
    SLDB annual net profit margin value is unknown

    Expenses

    Total expenses

    $129.73M
    SLDB annual total expenses is $129.73 million

    Operating expenses

    $129.73M
    SLDB annual total operating expenses is $129.73 million

    Cost of goods sold

    -
    SLDB annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $33.30M
    SLDB annual SGA is $33.30 million

    Depreciation and amortization

    $2.46M
    SLDB annual depreciation & amortization is $2.46 million

    Interest expense

    $340.00K
    SLDB annual interest expense is $340.00 thousand

    Income tax

    -
    SLDB annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$124.36M
    SLDB annual earnings before interest & taxes is -$124.36 million

    EBITDA

    -$121.90M
    SLDB annual EBITDA is -$121.90 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $188.66M
    SLDB annual total assets is $188.66 million

    Non current assets

    $31.36M
    SLDB annual long term assets is $31.36 million

    Current assets

    $157.30M
    SLDB annual total current assets is $157.30 million

    Cash and cash equivalents

    $80.23M
    SLDB annual cash & cash equivalents is $80.23 million

    Accounts receivable

    -
    SLDB annual accounts receivable value is unknown

    Inventory

    -
    SLDB annual inventory value is unknown

    Liabilities

    Total liabilities

    $51.42M
    SLDB annual total liabilities is $51.42 million

    Long term liabilities

    $21.16M
    SLDB annual total long term liabilities is $21.16 million

    Current liabilities

    $30.26M
    SLDB annual total current liabilities is $30.26 million

    Accounts payable

    $4.24M
    SLDB annual accounts payable is $4.24 million

    Debt

    Total debt

    $24.18M
    SLDB annual total debt is $24.18 million

    Total debt 1-year change

    -7.95%
    SLDB annual total debt is down -7.95% year-on-year

    Long term debt

    $21.16M
    SLDB annual long term debt is $21.16 million

    Short term debt

    $3.02M
    SLDB annual short term debt is $3.02 million

    Equity & Capital

    Shareholders equity

    $137.25M
    SLDB annual stockholders equity is $137.25 million

    Book value

    $137.25M
    SLDB annual book value is $137.25 million

    Retained earnings

    -$783.45M
    SLDB annual retained earnings is -$783.45 million

    Working capital

    $127.05M
    SLDB annual working capital is $127.05 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$100.01M
    SLDB annual cash flow from operations is -$100.01 million

    Cash from operations 1-year change

    -6.19%
    SLDB annual cash flow from operations is down -6.19% year-on-year

    Cash from investing

    -$16.09M
    SLDB annual cash flow from investing activities is -$16.09 million

    Cash from investing 1-year change

    -266.02%
    SLDB annual cash flow from investing activities is down -266.02% year-on-year

    Cash from financing

    $122.44M
    SLDB annual cash flow from financing activities is $122.44 million

    Cash from financing 1-year change

    +3821.75%
    SLDB annual cash flow from financing activities is up +3821.75% year-on-year

    CAPEX

    CAPEX

    -
    SLDB annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    SLDB annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$100.67M
    SLDB annual free cash flow is -$100.67 million

    Free cash flow 1-year change

    -5.19%
    SLDB annual free cash flow is down -5.19% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    SLDB annual gross profit margin value is unknown

    Operating margin

    -
    SLDB annual operating profit margin value is unknown

    Net margin

    -
    SLDB annual net profit margin value is unknown

    ROA & ROE

    ROA

    -66.10%
    SLDB annual return on assets is -66.10%

    ROE

    -90.86%
    SLDB annual return on equity is -90.86%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    SLDB price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    SLDB price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.32
    SLDB price to book ratio is 1.32

    PB ratio Sector rank

    45.57%
    SLDB price to book ratio is higher than 45.57% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    SLDB price to sales ratio value is unknown

    PS ratio Sector rank

    -
    SLDB price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $202.90M
    SLDB enterprise value is $202.90 million

    Enterprise value Sector rank

    55.09%
    SLDB enterprise value is higher than 55.09% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.48
    SLDB EV/EBITDA is -1.48

    EV/EBITDA Sector rank

    42.62%
    SLDB EV/EBITDA is higher than 42.62% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    5.20
    SLDB annual current ratio is 5.20

    Quick ratio

    -
    SLDB annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.18
    SLDB annual debt to equity ratio is 0.18

    Interest coverage ratio

    -365.76
    SLDB annual interest coverage ratio is -365.76

    Risk & Stability

    Piotroski F-Score

    -
    SLDB piotroski f-score value is unknown

    Altman Z-Score

    -
    SLDB altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Jun 6, 25 JMP Securities
    Market Outperform
    May 19, 25 Chardan Capital
    Buy
    May 16, 25 Wedbush
    Outperform
    May 16, 25 Piper Sandler
    Overweight
    May 16, 25 Barclays
    Overweight
    Mar 13, 25 JP Morgan
    Overweight
    Mar 10, 25 HC Wainwright & Co.
    Buy
    Mar 7, 25 Citizens Capital Markets
    Market Outperform
    Mar 7, 25 Chardan Capital
    Buy
    Feb 19, 25 Chardan Capital
    Buy

    Institutional Ownership

    Screeners with SLDB included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Solid Biosciences?
    • Does Solid Biosciences pay dividends?
    • What sector is Solid Biosciences in?
    • What industry is Solid Biosciences in?
    • What country is Solid Biosciences based in?
    • When did Solid Biosciences go public?
    • Is Solid Biosciences in the S&P 500?
    • Is Solid Biosciences in the NASDAQ 100?
    • Is Solid Biosciences in the Dow Jones?
    • When was Solid Biosciences's last earnings report?
    • When does Solid Biosciences report earnings?

    What is the ticker symbol for Solid Biosciences?

    The ticker symbol for Solid Biosciences is NASDAQ:SLDB

    Does Solid Biosciences pay dividends?

    No, Solid Biosciences does not pay dividends

    What sector is Solid Biosciences in?

    Solid Biosciences is in the Healthcare sector

    What industry is Solid Biosciences in?

    Solid Biosciences is in the Biotechnology industry

    What country is Solid Biosciences based in?

    Solid Biosciences is headquartered in United States

    When did Solid Biosciences go public?

    Solid Biosciences's initial public offering (IPO) was on January 26, 2018

    Is Solid Biosciences in the S&P 500?

    No, Solid Biosciences is not included in the S&P 500 index

    Is Solid Biosciences in the NASDAQ 100?

    No, Solid Biosciences is not included in the NASDAQ 100 index

    Is Solid Biosciences in the Dow Jones?

    No, Solid Biosciences is not included in the Dow Jones index

    When was Solid Biosciences's last earnings report?

    Solid Biosciences's most recent earnings report was on May 15, 2025

    When does Solid Biosciences report earnings?

    The next expected earnings date for Solid Biosciences is August 13, 2025
    On this page